Table 3.
A summary of pooled results from the included articles
| Variable | All patients | Severe | Non-severe | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of articles | I- squared | Prevalence % (95% CI) | Number of articles | I- squared | Prevalence % (95% CI) | Number of articles | I- squared | Prevalence % (95% CI) | |
| Clinical outcomes | |||||||||
| Discharged | 23 | 99.88 | 55 (38-72) | 8 | 98.52 | 32 (19-44) | 4 | 99.97 | 53 (-3-109) |
| Death | 22 | 99.97 | 19 (1-37) | 10 | 99.87 | 55 (45-66) | 3 | 43.21 | 0 (0-1) |
| Hospitalization | 15 | 99.85 | 80 (69-90) | - | - | - | - | - | - |
| ICU admission | 22 | 99.93 | 25 (3-47) | - | - | - | - | - | - |
| Laboratory findings | |||||||||
| Increase in ALT | 20 | 91.30 | 17 (13-21) | 10 | 97.47 | 38 (18-58) | 6 | 97.09 | 30 (16-44) |
| Increase in AST | 19 | 92.59 | 18 (14-23) | 11 | 94.03 | 48 (34-63) | 8 | 90.79 | 21 (13-29) |
| Increase in total bilirubin | 8 | 90.69 | 12 (7-17) | 4 | 66.67 | 17 (9-25) | 2 | - | 10 (7-12) |
| Decrease in albumin | 6 | 99.87 | 44 (0-88) | 3 | - | 36 (4-67) | - | - | - |
| Increase in C-Reactive Protein | 18 | 96.66 | 53 (43-62) | 10 | 96.07 | 78 (69-88) | 7 | 98.57 | 55 (36-73) |
| Increase in LDH | 18 | 98.23 | 36 (25-47) | 9 | 97.36 | 75 (62-87) | 4 | 71.85 | 39 (28-49) |
| Increase in ESR | 9 | 91.90 | 57 (44-70) | - | - | - | - | - | - |
| Increase in D-dimer | 17 | 97.97 | 35 (24-47) | 9 | 94.70 | 79 (70-89) | 6 | 96.07 | 28 (14-41) |
| Complication | |||||||||
| Liver toxicity | 13 | 95.35 | 20 (14-26) | 7 | 97.23 | 41 (19-62) | 2 | - | 17 (13-20) |